Published Erratum Ahead of print
PubMed: 41864751 DOI: 10.1016/j.jconrel.2026.114813
Retraction notice to 'Nitric oxide releasing nanofibrous Fmoc-dipeptide hydrogels for amelioration of renal ischemia/reperfusion injury' [Journal of Controlled Release 337 (2021) 1-13].
J Control Release
Authors: Haniyeh Najafi, Samira Sadat Abolmaali, Reza Heidari, Hadi Valizadeh, Mahboobeh Jafari, Ali Mohammad Tamaddon, Negar Azarpira
Affiliations
- Pharmaceutical Nanotechnology Department, Shiraz School of Pharmacy, Shiraz University of Medical Sciences, Shiraz 7146864685, Iran.
- Pharmaceutical Nanotechnology Department, Shiraz School of Pharmacy, Shiraz University of Medical Sciences, Shiraz 7146864685, Iran; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz 7146864685, Iran.
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz 7146864685, Iran.
- Pharmaceutics Department, Tabriz University of Medical Sciences, Tabriz, Iran.
- Transplant Research Center, Shiraz University of Medical Sciences, Mohammad Rasoul-allah Research Tower, Shiraz 7193711351, Iran.
MeSH
Dipeptides, Hydrogels, Pharmaceutical Preparations, Dosage Forms, Reperfusion, Reperfusion Injury, Ischemia